Lista de obras -

Combining liver stiffness with hyaluronic acid provides superior prognostic performance in chronic hepatitis C

artículo científico publicado en 2019

Controlled attenuation parameter is a novel technique in screening for non-alcoholic fatty liver disease ⬇️

artículo científico publicado en 2018

Feasibility of transient elastography versus real-time two-dimensional shear wave elastography in difficult-to-scan patients

artículo científico publicado en 2016

HBeAg and not genotypes predicts viral load in patients with hepatitis B in Denmark: A nationwide cohort study ⬇️

artículo científico publicado el 29 de septiembre de 2011

Hepatitis C prevalence in Denmark in 2016-An updated estimate using multiple national registers

artículo científico publicado en 2020

Hepatitis C--a disease coming out in the cold

artículo científico publicado el 9 de mayo de 2011

Incidence, prevalence and risk factors for hepatitis C in Danish prisons

artículo científico publicado en 2019

Influence of hepatitis C virus and IL28B genotypes on liver stiffness

artículo científico publicado en 2014

Liver mortality attributable to chronic hepatitis C virus infection in Denmark and Scotland--using spontaneous resolvers as the benchmark comparator

artículo científico publicado en 2016

Liver stiffness measurement among patients with chronic hepatitis B and C: results from a 5-year prospective study

artículo científico publicado en 2014

Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: a pilot study

artículo científico publicado en 2013

Microfibrillar-Associated Protein 4: A Potential Biomarker for Screening for Liver Fibrosis in a Mixed Patient Cohort

artículo científico publicado en 2015

No transmission of blood-borne viruses among hospital staff despite frequent blood exposure.

artículo científico publicado en 2014

Outcome and adverse events in patients with chronic hepatitis C treated with direct-acting antivirals: a clinical randomized study

artículo científico publicado en 2018

PNPLA 3I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection ⬇️

artículo científico publicado el 14 de septiembre de 2012

Randomized Trial Evaluating the Impact of Ribavirin Mono-Therapy and Double Dosing on Viral Kinetics, Ribavirin Pharmacokinetics and Anemia in Hepatitis C Virus Genotype 1 Infection

artículo científico publicado en 2016

Reply: To PMID 24519039.

artículo científico publicado en 2014

Retreatment with peg-interferon and ribavirin in patients with chronic hepatitis C virus genotype 2 or 3 infection with prior relapse

artículo científico publicado en 2013

Test uptake and Hepatitis C prevalence in 5483 Danish people in drug use treatment from 1996 to 2015: A register based cohort study

artículo científico publicado en 2018

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

artículo científico publicado en 2014

Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection

artículo científico publicado en 2008

Lista de obras de

Combining liver stiffness with hyaluronic acid provides superior prognostic performance in chronic hepatitis C

Controlled attenuation parameter is a novel technique in screening for non-alcoholic fatty liver disease ⬇️

Feasibility of transient elastography versus real-time two-dimensional shear wave elastography in difficult-to-scan patients

HBeAg and not genotypes predicts viral load in patients with hepatitis B in Denmark: A nationwide cohort study ⬇️

Hepatitis C prevalence in Denmark in 2016-An updated estimate using multiple national registers

Hepatitis C--a disease coming out in the cold

Incidence, prevalence and risk factors for hepatitis C in Danish prisons

Influence of hepatitis C virus and IL28B genotypes on liver stiffness

Liver mortality attributable to chronic hepatitis C virus infection in Denmark and Scotland--using spontaneous resolvers as the benchmark comparator

Liver stiffness measurement among patients with chronic hepatitis B and C: results from a 5-year prospective study

Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: a pilot study

Microfibrillar-Associated Protein 4: A Potential Biomarker for Screening for Liver Fibrosis in a Mixed Patient Cohort

No transmission of blood-borne viruses among hospital staff despite frequent blood exposure.

Outcome and adverse events in patients with chronic hepatitis C treated with direct-acting antivirals: a clinical randomized study

PNPLA 3I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection ⬇️

Randomized Trial Evaluating the Impact of Ribavirin Mono-Therapy and Double Dosing on Viral Kinetics, Ribavirin Pharmacokinetics and Anemia in Hepatitis C Virus Genotype 1 Infection

Reply: To PMID 24519039.

Retreatment with peg-interferon and ribavirin in patients with chronic hepatitis C virus genotype 2 or 3 infection with prior relapse

Test uptake and Hepatitis C prevalence in 5483 Danish people in drug use treatment from 1996 to 2015: A register based cohort study

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection

[In Process Citation] ⬇️

[Liver fibrosis can be assessed by non-invasive ultrasound elastography]